MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13023-019-1080-y

Медицинская библиотека · Orphanet journal of rare diseases · 2019

Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.

Akyol Mehmet Umut, Alden Tord D, Amartino Hernan, Ashworth Jane, Belani Kumar, Berger Kenneth I, Borgo Andrea, Braunlin Elizabeth, Eto Yoshikatsu, Gold Jeffrey I, Jester Andrea, Jones Simon A, Karsli Cengiz, Mackenzie William, Marinho Diane Ruschel, McFadyen Andrew, McGill Jim, Mitchell John J, Muenzer Joseph, Okuyama Torayuki, Orchard Paul J, Stevens Bob, Thomas Sophie, Walker Robert, Wynn Robert, Giugliani Roberto, Harmatz Paul, Hendriksz Christian, Scarpa Maurizio, MPS Consensus Programme Steering Committee, MPS Consensus Programme Co-Chairs

СтатьяПоддержка исследования: вне правительства СШАConsensus StatementПеревод пока не подготовлен

Аннотация

INTRODUCTION

Mucopolysaccharidosis (MPS) VI or Maroteaux-Lamy syndrome (253200) is an autosomal recessive lysosomal storage disorder caused by deficiency in N-acetylgalactosamine-4-sulfatase (arylsulfatase B). The heterogeneity and progressive nature of MPS VI necessitates a multidisciplinary team approach and there is a need for robust guidance to achieve optimal management. This programme was convened to develop evidence-based, expert-agreed recommendations for the general principles of management, routine monitoring requirements and the use of medical and surgical interventions in patients with MPS VI.

METHODS

26 international healthcare professionals from various disciplines, all with expertise in managing MPS VI, and three patient advocates formed the Steering Committee group (SC) and contributed to the development of this guidance. Members from six Patient Advocacy Groups (PAGs) acted as advisors and attended interviews to ensure representation of the patient perspective. A modified-Delphi methodology was used to demonstrate consensus among a wider group of healthcare professionals with expertise and experience managing patients with MPS VI and the manuscript has been evaluated against the validated Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument by three independent reviewers.

RESULTS

A total of 93 guidance statements were developed covering five domains: (1) general management principles; (2) recommended routine monitoring and assessments; (3) enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT); (4) interventions to support respiratory and sleep disorders; (5) anaesthetics and surgical interventions. Consensus was reached on all statements after two rounds of voting. The greatest challenges faced by patients as relayed by consultation with PAGs were deficits in endurance, dexterity, hearing, vision and respiratory function. The overall guideline AGREE II assessment score obtained for the development of the guidance was 5.3/7 (where 1 represents the lowest quality and 7 represents the highest quality of guidance).

CONCLUSION

This manuscript provides evidence- and consensus-based recommendations for the management of patients with MPS VI and is for use by healthcare professionals that manage the holistic care of patients with the intention to improve clinical- and patient-reported outcomes and enhance patient quality of life. It is recognised that the guidance provided represents a point in time and further research is required to address current knowledge and evidence gaps.

Для цитирования: Akyol Mehmet Umut, Alden Tord D, Amartino Hernan, Ashworth Jane, Belani Kumar, Berger Kenneth I, Borgo Andrea, Braunlin Elizabeth, Eto Yoshikatsu, Gold Jeffrey I, Jester Andrea, Jones Simon A, Karsli Cengiz, Mackenzie William, Marinho Diane Ruschel, McFadyen Andrew, McGill Jim, Mitchell John J, Muenzer Joseph, Okuyama Torayuki, Orchard Paul J, Stevens Bob, Thomas Sophie, Walker Robert, Wynn Robert, Giugliani Roberto, Harmatz Paul, Hendriksz Christian, Scarpa Maurizio, MPS Consensus Programme Steering Committee, MPS Consensus Programme Co-Chairs. Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.. Orphanet journal of rare diseases. 2019. DOI: 10.1186/s13023-019-1080-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.